Much like 'chicken pox parties' that health authorities have long tried to halt, at least two instances of 'Covid-19 parties' have been identified as people want to quickly contract the disease in the hope to build immunity
'Becoming', now on Netflix, is not the candid Michelle Obama film that people might have been waiting for. Instead, we get a familiar, albeit more carefree, former first lady
With venues shut, artistes are moving to digital events and finding new audiences
In a virtual panel discussion, Forbes India editor Brian Carvalho discussed the future of Indian luxury with leaders including Manish Malhotra, Manish Mehrotra, Sharad Agarwal, Kapil Chopra, Vikas Purohit, Daniel Andre Langer and Abhay Gupta
Our latest edition takes a look at how India's economy can be rebooted as we continue to cope with the Covid-19 pandemic and its fallout; plus why CEOs think India is ready to embrace work from home even well past the lockdown
About 5,000 people have been affected and 8 have died so far after a lethal leakage was reported from an industrial unit in Andhra Pradesh
Would you go back to an office full-time once the lockdown lifts, or prefer to follow a hybrid model? Some of the country's most prominent leaders see advantages in giving employees the freedom to choose even after the pandemic
It's one of the few companies doing financially well through the pandemic, but Domino's employees have been striking to demand better conditions and protection after several co-workers have tested positive for Covid-19. Does it take an outbreak and a strike for companies to do what's right?
The coronavirus outbreak has adversely affected several businesses, but not all is lost yet. Many, especially those in the pharma and consumer goods space, are expected to bounce back strongly in the post-Covid-19 world
As India prepares to undertake its largest repatriation mission, we take a look at the plan to bring back 1.92 lakh Indians stranded in 12 countries, how it will work, and some crucial repatriation exercises of the past
A firm called Takis is said to have developed a vaccine with antibodies generated in mice, which may work on human cells too; human testing is likely to begin after the summer